Luzzati Roberto, Zerbato Verena, Attard Luciano, Virgili Giulio, Cilli Alessandro, Zanier Ada, Libanore Marco, Segala Daniela, Tedesco Andrea, Bortolotti Maria Elena, Pontali Emanuele, Feasi Marcello, Re Azzurra, Giarretta Igor, Pomero Fulvio, Zagarrì Elisa, Concia Ercole, Dentali Francesco, Manfellotto Dario, Campanini Mauro
Infectious Disease Unit, Trieste University Hospital, ASUGI , Trieste, Italy.
Infectious Diseases Unit, Department for Integrated Infectious Risk Management, IRCCS Policlinico S. Orsola-Malpighi Hospital, AUSL Bologna-IRCCS IOR Bologna-AUSL, Imola, Italy.
Intern Emerg Med. 2025 Aug 19. doi: 10.1007/s11739-025-04084-1.
Fever of Unknown Origin (FUO) remains a diagnostic challenge, defined by prolonged fever lasting for more than three weeks without a clear cause despite a minimum of three days of hospital investigations or three outpatient visits at least. This study aims to explore the etiologies and potential predictive factors for classic FUO in Italy, updating prior data from earlier studies. Conducted from October 2019 to June 2023, this prospective, multi-center registry enrolled 188 patients from 25 Italian hospitals, assessing demographics, comorbidities, and clinical characteristics in relation to FUO causes. Results indicated that 72.1% of cases reached a final diagnosis, with etiologies primarily in non-infectious inflammatory (31.8%), infectious (25.7%), and neoplastic (8.4%) categories, while 27.9% remained undiagnosed. Younger patients (under 55 years) were more likely to lack a definitive diagnosis, suggesting that advanced investigations might benefit early this patient population. Comorbid conditions like chronic obstructive pulmonary disease and cardiovascular symptoms were associated with infectious causes, whereas musculoskeletal and dermatologic signs suggested a non-infectious inflammatory origin. The overall mortality rate was 2.8% at a 6-month follow-up. This study highlights the need for improved diagnostic tools to address the substantial number of undiagnosed FUO cases. Trial registration: NCT05254522 ClinicalTrials.gov identifier.
不明原因发热(FUO)仍然是一个诊断难题,其定义为持续发热超过三周,尽管进行了至少三天的住院检查或至少三次门诊就诊,但仍无明确病因。本研究旨在探讨意大利经典FUO的病因及潜在预测因素,更新早期研究的既往数据。该前瞻性多中心注册研究于2019年10月至2023年6月进行,纳入了来自25家意大利医院的188例患者,评估了与FUO病因相关的人口统计学、合并症和临床特征。结果表明,72.1%的病例获得了最终诊断,病因主要为非感染性炎症(31.8%)、感染性(25.7%)和肿瘤性(8.4%),而27.9%的病例仍未确诊。年轻患者(55岁以下)更有可能缺乏明确诊断,这表明进一步的检查可能对这一患者群体早期有益。慢性阻塞性肺疾病和心血管症状等合并症与感染性病因相关,而肌肉骨骼和皮肤体征提示非感染性炎症起源。在6个月的随访中,总死亡率为2.8%。本研究强调需要改进诊断工具以解决大量未确诊的FUO病例。试验注册:NCT05254522(ClinicalTrials.gov标识符)